TAS-102 tablets
Sponsors
Taiho Oncology, Inc.
Conditions
Advanced Solid TumorsAdvanced Solid Tumors (Excluding Breast Cancer)
Phase 1
Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPI
CompletedNCT01874522
Start: 2013-07-31End: 2015-11-30Updated: 2024-09-05
Study of the Mass Balance of Oral FTD and TPI as Components of TAS-102 in Patients With Advanced Solid Tumors
CompletedNCT02031055
Start: 2014-02-28End: 2015-06-17Updated: 2024-09-05